A Qualified Applicant (shortened to QA) is a person with Spina Bifida (or that person’s parent/guardian) who resides in Massachusetts or a New England state that does not have an SBA affiliated entity.
How much is the benefit?
The benefit for 2012 is up to a maximum of $425 for the calendar year. Because benefits are available to each person with Spina Bifida, a family with more than one person with Spina Bifida would qualify for up to the maximum of $425 per person with Spina Bifida. See the Official Benefits Program Posting for a complete explanation of the distribution policy.
What Kinds of Expenses Qualify?
The benefit shall be used to reimburse for unpaid medical expenses and unpaid therapy (OT, PT) related directly to an individual’s Spina Bifida; adaptive equipment; urological supplies; durable medical equipment; adaptive driving lessons; auto modifications; home accessibility modifications; camp; adaptive sports and recreation activities.
When Should I Apply for Benefits?
Benefits will be reviewed and distributed on quarterly basis. To apply for the 2012 benefit, the complete submission must be made via fax, email, online or postmarked prior to:
Submit prior to midnight on the dates listed above to be reviewed for that quarter.
Benefits applications will be returned, with an explanation, if received without proper documentation or if denied. QA may then resubmit a compliant submission.
Download the 2012 OFFICIAL POSTING. This document includes important information and is a must-read for all applicants.
Latest News
Paralympics power-lifting star, Anderson “Andy” Wise is walking ‘n rolling to support people living with Spina Bifida
The MetroWest Women's Alliance is a collaborative initiative of the United Way of Tri-County and the MetroWest Chamber of Commerce. This organization was created with all MetroWest women and girls in mind.
This year’s National Conference will feature findings from the Second World Congress on Spina Bifida Research and Care, SBA’s international meeting of Spina Bifida health care providers and researchers. Be the first to hear about the latest in care treatment and what is on the horizon for this challenging condition!